India Faces Rising Metabolic Disease Burden, Global Study Warns

India and China account for the highest absolute metabolic disease burdens in the Asia-Pacific region, according to a recent analysis of the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) covering the period from 1990 to 2023. The study, published in the peer-reviewed journal “Metabolism”, also provides projections up to 2030. Researchers analysed key indicators such as disability-adjusted life years (DALYs) and mortality linked to major metabolic diseases and risk factors across the region.

Understanding Metabolic Diseases

Metabolic diseases arise when the body’s normal processes of breaking down, storing or using energy from food are disrupted. These disorders are influenced by factors such as diet, lifestyle, genetics and environmental conditions. The study examined five major metabolic conditions and risk factors: Type 2 diabetes mellitus, high systolic blood pressure, high body mass index (BMI), high low-density lipoprotein (LDL) cholesterol and metabolic dysfunction-associated steatotic liver disease (MASLD). Together, these conditions significantly contribute to long-term disability and premature mortality.

India’s Growing Health Burden

The analysis shows that India and China dominate the regional burden of metabolic diseases. In 2023 alone, India recorded approximately 21 million DALYs and around 5.8 lakh deaths linked to Type 2 diabetes. High systolic blood pressure contributed nearly 3.8 crore DALYs and about 15.7 lakh deaths. Rising levels of high BMI, LDL cholesterol and MASLD are also adding to the country’s health challenges. In terms of DALYs, India surpassed China in 2023 to become the leading country in the region for metabolic disease burden.

Rising Risk Factors and Future Trends

Experts warn that several metabolic risk factors in India continue to increase steadily. High BMI, in particular, has been rising at an annual rate of roughly 2.7 to 2.9 percent. Similar trends are observed for LDL cholesterol and fatty liver disease. If these patterns continue, the overall metabolic disease burden in the Asia-Pacific region is expected to grow further by 2030, placing additional pressure on health systems.

Important Facts for Exams

• The Global Burden of Disease (GBD) Study measures health loss through indicators such as disability-adjusted life years (DALYs).
• DALYs combine years of life lost due to premature death with years lived with disability.
• Type 2 diabetes, high blood pressure and obesity are major contributors to non-communicable diseases worldwide.
• Metabolic dysfunction-associated steatotic liver disease (MASLD) refers to fatty liver disease linked to metabolic risk factors.

Need for Integrated Prevention Strategies

Health experts emphasise the need for urgent preventive measures to address the growing metabolic disease burden. Key recommendations include promoting healthier diets through regulation of ultra-processed foods, clear front-of-pack nutrition labelling and reduction of excessive sugar, salt and unhealthy fats in everyday foods. Urban planning that encourages physical activity through safe walking paths, cycling tracks and community exercise programmes is also essential. In addition, large-scale screening for obesity, diabetes, hypertension and fatty liver disease within primary health systems can help identify high-risk individuals and enable early intervention.